W. Prohaska

768 total citations
26 papers, 520 citations indexed

About

W. Prohaska is a scholar working on Surgery, Hematology and Epidemiology. According to data from OpenAlex, W. Prohaska has authored 26 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 6 papers in Hematology and 5 papers in Epidemiology. Recurrent topics in W. Prohaska's work include Blood Coagulation and Thrombosis Mechanisms (5 papers), Hepatitis C virus research (5 papers) and Hepatitis B Virus Studies (4 papers). W. Prohaska is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (5 papers), Hepatitis C virus research (5 papers) and Hepatitis B Virus Studies (4 papers). W. Prohaska collaborates with scholars based in Germany, United States and Denmark. W. Prohaska's co-authors include K Kleesiek, C Götting, Thomas Brinkmann, M Schmidt, Bernd Stratmann, Gero Tenderich, Reiner Köerfer, Michiel Morshuis, Andreas Greinacher and Armin Zittermann and has published in prestigious journals such as Blood, Journal of Thoracic and Cardiovascular Surgery and Journal of Thrombosis and Haemostasis.

In The Last Decade

W. Prohaska

26 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Prohaska Germany 11 209 167 140 88 83 26 520
L. Poll Germany 14 148 0.7× 73 0.4× 45 0.3× 139 1.6× 49 0.6× 35 876
Jaromír Gumulec Czechia 9 105 0.5× 90 0.5× 50 0.4× 79 0.9× 69 0.8× 17 311
Jildaz Caroff France 22 129 0.6× 18 0.1× 28 0.2× 40 0.5× 65 0.8× 85 1.2k
Sören Schenk United States 16 480 2.3× 131 0.8× 43 0.3× 100 1.1× 7 0.1× 37 839
Can Yerebakan Germany 17 588 2.8× 267 1.6× 27 0.2× 233 2.6× 19 0.2× 101 1.1k
Wojciech Pepke Germany 13 379 1.8× 50 0.3× 44 0.3× 62 0.7× 14 0.2× 34 558
Jerry E. Enis United States 10 289 1.4× 23 0.1× 59 0.4× 32 0.4× 11 0.1× 13 541
Bindu Bittira Canada 11 353 1.7× 281 1.7× 16 0.1× 110 1.3× 10 0.1× 16 636
Taro Saito Japan 13 156 0.7× 31 0.2× 125 0.9× 82 0.9× 5 0.1× 35 531
Chwan-Yau Luo Taiwan 16 466 2.2× 44 0.3× 15 0.1× 147 1.7× 19 0.2× 34 766

Countries citing papers authored by W. Prohaska

Since Specialization
Citations

This map shows the geographic impact of W. Prohaska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Prohaska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Prohaska more than expected).

Fields of papers citing papers by W. Prohaska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Prohaska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Prohaska. The network helps show where W. Prohaska may publish in the future.

Co-authorship network of co-authors of W. Prohaska

This figure shows the co-authorship network connecting the top 25 collaborators of W. Prohaska. A scholar is included among the top collaborators of W. Prohaska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Prohaska. W. Prohaska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stratmann, Bernd, W. Prohaska, H. Koerperich, et al.. (2012). Autologous stem cell therapy in the treatment of limb ischaemia induced chronic tissue ulcers of diabetic foot patients. International Journal of Clinical Practice. 66(4). 384–393. 125 indexed citations
2.
Greiner, Johannes F. W., Darius Widera, C. Dieter Zander, et al.. (2011). Efficient animal-serum free 3D cultivation method for adult human neural crest-derived stem cell therapeutics. European Cells and Materials. 22. 403–419. 44 indexed citations
3.
Prohaska, W., Armin Zittermann, Kazuo Inoue, et al.. (2008). Prevalent platelet dysfunction in patients with aortic valve disease.. PubMed. 17(5). 542–7. 21 indexed citations
4.
Prohaska, W., Armin Zittermann, Kenichi Inoue, et al.. (2008). Preoperative haemostasis testing does not predict requirement of blood products in cardiac surgery.. PubMed. 13(11). 525–30. 9 indexed citations
5.
Schenk, Sören, Michiel Morshuis, Latif Arusoglu, et al.. (2007). IgG classification of anti‐PF4/heparin antibodies to identify patients with heparin‐induced thrombocytopenia during mechanical circulatory support. Journal of Thrombosis and Haemostasis. 5(2). 235–241. 41 indexed citations
6.
Goltry, Kristin L., W. Prohaska, Diethelm Tschöpe, et al.. (2007). Good Manufacturing Practice-Compliant Expansion of Marrow-Derived Stem and Progenitor Cells for Cell Therapy. Cell Transplantation. 16(7). 685–696. 40 indexed citations
7.
Tenderich, Gero, Armin Zittermann, W. Prohaska, & Reiner Köerfer. (2007). No Evidence for an Improvement of Long-Term Survival by HLA Matching in Heart Transplant Recipients. Transplantation Proceedings. 39(5). 1575–1579. 14 indexed citations
8.
Schenk, Sören, Aly El‐Banayosy, W. Prohaska, et al.. (2006). Heparin-induced thrombocytopenia in patients receiving mechanical circulatory support. Journal of Thoracic and Cardiovascular Surgery. 131(6). 1373–1381.e4. 54 indexed citations
9.
Tenderich, Gero, Armin Zittermann, W. Prohaska, et al.. (2005). Frequent Detection of Hepatitis B Core Antibodies in Heart Transplant Recipients Without Preceding Hepatitis B Infection. Transplantation Proceedings. 37(10). 4522–4524. 9 indexed citations
10.
11.
Prohaska, W., et al.. (1999). Evaluation of a New Reagent for Preserving Fresh Blood Samples and Its Potential Usefulness for Internal Quality Controls of Multichannel Hematology Analyzers. American Journal of Clinical Pathology. 111(3). 387–396. 6 indexed citations
12.
Tiemann, Carsten, W. Prohaska, Reiner Körfer, et al.. (1997). Effect of Cyclosporine A on the Release of Tissue Factor Pathway Inhibitor from Endothelial Cells in Heart Transplant Patients and Cell Culture. Clinical Chemistry and Laboratory Medicine (CCLM). 35(9). 661–7. 7 indexed citations
13.
Baller, D., et al.. (1996). 34. Hyperfibrinogenemia in markedly obese patients with cardiovascular disease. Fibrinolysis and Proteolysis. 10. 10–11. 1 indexed citations
14.
Prohaska, W., Hermann Mannebach, M Schmidt, U Gleichmann, & K Kleesiek. (1995). Evidence against heterozygous coagulation factor V 1691 G?A mutation with resistance to activated protein C being a risk factor for coronary artery disease and myocardial infarction. Journal of Molecular Medicine. 73(10). 521–4. 19 indexed citations
15.
Brinkmann, Thomas, et al.. (1994). Synthesis of Tissue Factor Pathway Inhibitor in Human Synovial Cells and Chondrocytes Makes Joints the Predilected Site of Bleeding in Haemophiliacs. Clinical Chemistry and Laboratory Medicine (CCLM). 32(4). 313–318. 26 indexed citations
16.
Wolff, Carsten, Kathrin Schlüter, W. Prohaska, & K Kleesiek. (1992). Improved Detection of Hepatitis C Virus RNA by Reverse Transcription and Polymerase Chain Reaction. Clinical Chemistry and Laboratory Medicine (CCLM). 30(11). 717–27. 6 indexed citations
17.
18.
19.
Prohaska, W., Carsten Wolff, E. Lechler, & K Kleesiek. (1991). High rate of false positives in blood donor screening for antibodies to hepatitis C virus. Journal of Molecular Medicine. 69(7). 294–296. 6 indexed citations
20.
Prohaska, W. & V. Kretschmer. (1984). Simple Method for Preparation of Cryoprecipitate (CP) and Cryodepleted Plasma (CDP). Transfusion Medicine and Hemotherapy. 11(6). 342–344. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L. Poll Breakdown of academic impact, for papers by Jaromír Gumulec Breakdown of academic impact, for papers by Jildaz Caroff Breakdown of academic impact, for papers by Sören Schenk Breakdown of academic impact, for papers by Can Yerebakan Breakdown of academic impact, for papers by Wojciech Pepke Breakdown of academic impact, for papers by Jerry E. Enis Breakdown of academic impact, for papers by Bindu Bittira Breakdown of academic impact, for papers by Taro Saito Breakdown of academic impact, for papers by Chwan-Yau Luo
Rankless by CCL
2026